CAS: 1072833-77-2 - Ixazomib
Formula:C14H19BCl2N2O4
InChI:InChI=1S/C14H19BCl2N2O4/c1-8(2)5-12(15(22)23)19-13(20)7-18-14(21)10-6-9(16)3-4-11(10)17/h3-4,6,8,12,22-23H,5,7H2,1-2H3,(H,18,21)(H,19,20)/t12-/m0/s1
InChI key:InChIKey=MXAYKZJJDUDWDS-LBPRGKRZSA-N
SMILES:O=C(NCC(=O)NC(B(O)O)CC(C)C)C1=CC(Cl)=CC=C1Cl
- Synonyms:
- MLN 2238
- B-[(1R)-1-[[2-[(2,5-Dichlorobenzoyl)amino]acetyl]amino]-3-methylbutyl]boronic acid
- Ninlaro
- Boronic acid, B-[(1R)-1-[[2-[(2,5-dichlorobenzoyl)amino]acetyl]amino]-3-methylbutyl]-
- Ixazomib
Ixazomib
CAS:1072833-77-2
Formula:
C14H19BCl2N2O4
Purity:
98%
Color and Shape:
Solid
Molecular weight:
361.0287
Ref: IN-DA0037YJ
1g | To inquire | ||
5mg | 55.00 € | ||
10mg | 100.00 € | ||
25mg | 169.00 € | ||
50mg | 167.00 € | ||
100mg | 272.00 € | ||
250mg | 598.00 € |
Estimated delivery in United States, on Tuesday 7 Jan 2025
Ixazomib
CAS:1072833-77-2
Formula:
C14H19BCl2N2O4
Color and Shape:
White To Off-White Solid
Molecular weight:
361.03
Ref: 4Z-I-088001
10mg | To inquire | ||
25mg | To inquire | ||
50mg | To inquire | ||
100mg | To inquire |
Estimated delivery in United States, on Tuesday 7 Jan 2025
Ref: 4Z-I-088002
10mg | To inquire | ||
25mg | To inquire | ||
50mg | To inquire | ||
100mg | To inquire |
Estimated delivery in United States, on Monday 13 Jan 2025
Ref: 7W-GW1595
1mg | 95.00 € | ||
5mg | 237.00 € | ||
25mg | 679.00 € |
Estimated delivery in United States, on Monday 13 Jan 2025
Ixazomib
CAS:1072833-77-2
Ixazomib (MLN2238) is a boron-based peptide proteasome inhibitor targeting β5 site (IC50: 3.4 nM), also …
Formula:
C14H19BCl2N2O4
Purity:
98% - 98.92%
Color and Shape:
Solid
Molecular weight:
361.03
- Inhibitors
- Proteases/Proteasome
- Proteasome
- Autophagy
- See more categories
- Ixazomib and Impurities
Ref: TM-T2122
1mg | 48.00 € | ||
5mg | 93.00 € | ||
10mg | 124.00 € | ||
25mg | 274.00 € | ||
50mg | 460.00 € | ||
100mg | 639.00 € | ||
500mg | 1,328.00 € | ||
1mL*10mM (DMSO) | 96.00 € |
Estimated delivery in United States, on Monday 13 Jan 2025
Ixazomib-13C2,15N
Controlled ProductCAS:1072833-77-2
Applications Ixazomib-13C2,15N is derived from (αR)-(1S,2S,3R,5S)-Pinanediol-1-amino-3-methylbutane-1-boronate Trifluoroacetic Acid Salt (P458505), which is a Bortezomib (B675700) …
Formula:
C1213C2H19BCl2N15NO4
Color and Shape:
White To Off-White
Molecular weight:
364.01
Ref: TR-I942002
1mg | 328.00 € |
Estimated delivery in United States, on Tuesday 14 Jan 2025
Ixazomib
Controlled ProductCAS:1072833-77-2
Applications Ixazomib is a proteasome inhibitor that acts by preventing cell growth in solid tumours. …
Formula:
C14H19BCl2N2O4
Color and Shape:
Neat
Molecular weight:
361.03
Ref: TR-I942000
10mg | 219.00 € | ||
50mg | 669.00 € | ||
100mg | 1,090.00 € |
Estimated delivery in United States, on Tuesday 14 Jan 2025
Ixazomib
CAS:1072833-77-2
Proteosome inhibitor; antineoplastic
Formula:
C14H19BCl2N2O4
Purity:
Min. 95%
Color and Shape:
Powder
Molecular weight:
361.03 g/mol
Ref: 3D-FI65049
10mg | 214.00 € | ||
25mg | 447.00 € | ||
100mg | 854.00 € | ||
250mg | 1,339.00 € |
Estimated delivery in United States, on Monday 27 Jan 2025